DBV Technologies SA Sponsored ADR
(NASDAQ : DBVT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.31%186.671.1%$893.59m
GILDGilead Sciences, Inc.
1.90%80.910.9%$837.97m
CELGCelgene Corporation
1.95%95.611.2%$687.44m
BIIBBiogen Inc.
2.80%292.781.2%$564.73m
JUNOJuno Therapeutics, Inc.
0.02%86.5813.5%$436.33m
REGNRegeneron Pharmaceuticals, Inc.
2.55%323.862.7%$403.87m
VRTXVertex Pharmaceuticals Incorporated
5.27%165.901.9%$348.24m
ALXNAlexion Pharmaceuticals, Inc.
3.79%118.932.0%$257.26m
NKTRNektar Therapeutics
1.58%89.606.0%$256.22m
ILMNIllumina, Inc.
3.13%233.843.5%$231.09m
AAgilent Technologies, Inc.
0.03%70.701.5%$186.84m
BLUEBluebird Bio, Inc.
2.41%206.0516.1%$156.27m
INCYIncyte Corporation
3.06%87.802.5%$152.45m
EXASExact Sciences Corporation
-5.82%42.3726.0%$117.22m
BMRNBioMarin Pharmaceutical Inc.
-1.13%83.054.4%$116.68m

Company Profile

DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products. It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients. The company has designed two products candidates: Viaskin Peanut and Viaskin Milk. DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.